Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Olden, R. W.
Right arrow Articles by Arisz, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Olden, R. W.
Right arrow Articles by Arisz, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1995) 10: 2274-2280
© 1995 European Renal Association-European Dialysis and Transplant Association


research-article

Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments

R. W. van Olden1,, B. A. C. van Acker1, G. C. M. Koomen2, R. T. Krediet1 and L. Arisz1

1Renal Unit, Department of Medicine, Academic Medical Center, University of Amsterdam 2Clinical Chemistry, Academic Medical Center, University of Amsterdam

Correspondence and offprint requests to: Correspondence and offprint requests to: R. W. van Olden MD, Academic Medical Center, University of Amsterdam, Department of Nephrology, PO Box 22700, 1100 DE Amsterdam, The Netherlands

BACKGROUND: Urinary volume of haemodialysis patients with residual renal function increases during the interdialytic interval. The contribution of GFR to this change in water and solute excretion has not been quantified in detail. The creatinine clearance (Clc) as a determinant of the GFR may overestimate GFR caused by the tubular secretion of creatinine. Cimetidine has been used to inhibit the secretion of creatinine in non-dialysed patients. No data are available on its usefulness in haemodialysis patients.

METHODS: Two identical interdialytic intervals (DI) of 3 days (DI-1, DI-2) were investigated in 11 patients. The interval between DI-1 and DI-2 was 1 week. During DI-2 cimetidine 800 mg daily was administered. Each DI was divided in four urine-collection periods.

RESULTS: The water and solute excretion in DI-1 and DI-2 were similar. Urinary production increased from 0.37 ±0.30 ml/min to 0.66 ±0.33 ml/min (P<0.05), inulin clearance (C11) increased from 1.8±1.1 ml/min to 2.7 ± 1.2 ml/min (P<0.05), fractional sodium excretion from 9.0 ± 5.7% to 14.5 ± 9.0% (P<0.05). In contrast to Cli;; the Clc showed no increase during the interdialytic interval both in DI-1 and DI-2. The overestimation of GFR by creatinine (Cli Cli) decreased during DI-1 from 1.35 ±1.69 ml/min to 0.26 ± 0.60 (P<0.05) and during DI-2 from 1.01 ±1.33 ml/min to 0.10 ± 0.67 (P<0.01). The ratio Clc/Cli decreased during DI-1 from 1.78 ± 0.53 to 1.09 ± 0.19 (P< 0.01) and during DI-2 from 2.02 ±1.13 to 1.05 ± 0.30 (P<0.01). All parameters were not different between the comparable days of DI-1 and DI-2.

CONCLUSION: We conclude that the urinary volume in the interdialytic interval is directly related to changes in GFR. During the interdialytic interval GFR increased and tubular secretion of creatinine decreased. The administration of cimetidine did not improve the accuracy of Clc as a measurement of GFR in end-stage renal failure.

Keywords: cimetidine; creatinine clearance; haemodialysis; inulin clearance; interdialytic interval; residual renal function


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. J. Davies, E. G. Lopez, G. Woodrow, K. Donovan, J. Plum, P. Williams, A. C. Johansson, H.-P. Bosselmann, O. Heimburger, O. Simonsen, et al.
Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2982 - 2988.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. M. MOIST, F. K. PORT, S. M. ORZOL, E. W. YOUNG, T. OSTBYE, R. A. WOLFE, T. HULBERT-SHEARON, C. A. JONES, and W. E. BLOEMBERGEN
Predictors of Loss of Residual Renal Function among New Dialysis Patients
J. Am. Soc. Nephrol., March 1, 2000; 11(3): 556 - 564.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.